Aflac Incorporated Revenue & Financials

Aflac Incorporated reported total revenues of $17.4 billion for the fiscal year 2024, representing a steady performance driven by robust net investment income and stable premium growth across its US and Japanese segments. The company’s net earnings for the year reached approximately $4.5 billion, translating to diluted earnings per share of roughly $8.50, a testament to the company’s disciplined expense management and its aggressive share repurchase program, which has significantly reduced the outstanding share count over the past decade. The financial architecture of Aflac is built on two primary pillars: net earned premiums and net investment income. Net earned premiums, which totaled approximately $12.5 billion in 2024, were driven by strong renewal retention rates in both the US and Japan, offset slightly by the impact of foreign exchange fluctuations on the Japanese yen and competitive pricing pressures in the US supplemental market. The US segment generated approximately $4.5 billion in net earned premiums, reflecting the continued shift toward high-deductible health plans that drive demand for Aflac’s accident, critical illness, and hospital indemnity products. The Japanese segment, which remains the company’s largest premium generator, produced over $8.0 billion in net earned premiums, demonstrating the enduring demand for Aflac’s cancer and medical insurance products despite the demographic headwinds of an aging population. Net investment income, the second pillar of Aflac’s financial performance, generated approximately $5.5 billion in 2024, a significant increase from previous years as the company successfully reinvested maturing bonds and new premium cash flows into higher-yielding fixed-income securities in the sustained higher-interest-rate environment. The yield on Aflac’s $160 billion investment portfolio increased by approximately 30 basis points year-over-year, reaching roughly 4.8%, providing a substantial boost to the company’s bottom line and demonstrating the effectiveness of its investment strategy in navigating the macroeconomic environment. The company’s combined ratio, a key metric of underwriting profitability that measures incurred losses and expenses relative to earned premiums, remained highly competitive at approximately 94%, indicating that for every dollar of premium collected, Aflac paid out 94 cents in claims and expenses, generating a 6-cent underwriting profit. This underwriting discipline, combined with the strong investment yield, allowed Aflac to generate massive free cash flow, which the company aggressively returned to shareholders. Aflac’s capital allocation strategy is strictly disciplined, targeting the return of over 100% of its adjusted free cash flow to shareholders through a combination of quarterly dividends and share repurchases. In 2024, the company paid out approximately $1.5 billion in dividends and repurchased over $2.0 billion of its own stock, a commitment that has driven a 40% reduction in its outstanding share count over the past decade and consistently supported earnings per share growth. The company’s return on equity (ROE) remained strong at approximately 14%, reflecting its ability to generate attractive returns on the substantial capital base required to support its insurance operations and its massive investment portfolio. Aflac’s balance sheet remains exceptionally strong, with statutory capital ratios well above the regulatory minimums required by the National Association of Insurance Commissioners (NAIC) in the US and the Financial Services Agency (FSA) in Japan, providing the company with the financial flexibility to absorb potential shocks, such as a severe pandemic or a natural disaster, while still meeting its obligations to policyholders and shareholders. The company’s debt-to-capital ratio is conservatively managed at approximately 25%, ensuring that Aflac maintains a strong credit rating from major rating agencies, which in turn keeps its borrowing costs low and enhances its competitive position when negotiating reinsurance treaties and other financial agreements. Aflac’s financial performance in 2024 demonstrates the resilience of its business model, its ability to adapt to a changing macroeconomic environment, and its unwavering commitment to generating long-term value for its shareholders through disciplined underwriting, prudent investment management, and aggressive capital return. The company's operating cash flow remained robust, generating over $6 billion in liquidity that provided the necessary capital to fund its daily operations, pay claims, and execute its strategic initiatives without relying on external debt markets, a testament to the self-funding nature of its highly profitable insurance operations.